These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21018391)

  • 1. [New contributions to the treatment of infantile kala-azar by antimony hexonate in oily and concentrated solution].
    FERNANDEZ CASTANYS A
    Rev Sanid; 1945 Feb; 19():114-24. PubMed ID: 21018391
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of kala-azar with sodium antimony-v-gluconate; preliminary observations.
    SEN GUPTA PC; CHAKRAVARTY NK
    Ind Med Gaz; 1945 Nov; 80(11):560-4. PubMed ID: 21022523
    [No Abstract]   [Full Text] [Related]  

  • 3. [New Contributions To the Chemotherapy Of Infantile Kala-Azar By Concentrated Solustibosan].
    LOZANO MORALES A
    Rev Sanid; 1945 Aug; 19():529-35. PubMed ID: 21013091
    [No Abstract]   [Full Text] [Related]  

  • 4. A new sodium antimony gluconate for the treatment of kala-azar.
    DASTIDAR SK
    J Indian Med Assoc; 1945 Sep; 14():298. PubMed ID: 21003768
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the treatment of 25 cases of kala-azar with stibatin (sodium antimony gluconate).
    CHOUDHURI RK
    Ind Med Gaz; 1946; 81(4-5):174-6. PubMed ID: 20291436
    [No Abstract]   [Full Text] [Related]  

  • 6. Agranulocytosis following antimony therapy in kala-azar.
    BRAHMACHARI PN; MAITI CR; KAR CC
    J Indian Med Assoc; 1955 Oct; 25(10):408-10. PubMed ID: 13278551
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-Kala-Azar dermal leishmaniasis; a report of two typical cases with special reference to result of intensive antimonial therapy.
    TZU-TA C; PANG-MU C; LEE-SHIH L
    Chin Med J; 1953; 71(5):334-42. PubMed ID: 13127100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of kala-azar with a new stoibi compound; 2.168 R. P. (First Results)].
    DURAND P; BENMUSSA S; CARUANA M
    Bull Mem Soc Med Hop Paris; 1946 Jul 5-12; 62(24-25):399-409. PubMed ID: 20246401
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antimony therapy in visceral leishmaniasis].
    SAN ANTONIO ALVAREZ J
    Farmacoter Actual; 1945 Feb; 2(2):109-22. PubMed ID: 20994166
    [No Abstract]   [Full Text] [Related]  

  • 11. On the toxicity of some organic antimonial drugs used for the treatment of kala-azar.
    BOSE AN; GHOSH TN
    Ind Med Gaz; 1946 Jan; 81(1):13-6. PubMed ID: 21025569
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimony dextran complex in the treatment of leishmaniasis.
    SEN GUPTA PC; CHATTERJI A; MUKHERJEE AM
    J Indian Med Assoc; 1961 Dec; 37():585-90. PubMed ID: 13910615
    [No Abstract]   [Full Text] [Related]  

  • 13. The correlation between distribution of antimony in tissues and chemotherapeutic effect in experimental leishmaniasis.
    GELLHORN A; VAN DYKE HB
    J Pharmacol Exp Ther; 1946 Oct; 88(2):162-72. PubMed ID: 20274538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
    GIRAUD P; BERNARD R; VINCENT P
    Arch Fr Pediatr; 1954; 11(6):659-62. PubMed ID: 13198287
    [No Abstract]   [Full Text] [Related]  

  • 15. [New observations on the treatment of cutaneous leishmaniasis by antimon-detoxin].
    PESSOA SB; VILLELA F
    Rev Paul Med; 1946 Mar; 28(3):201. PubMed ID: 20281154
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on the use of sodium antimony gluconate (sodium stibogluconate) in the treatment of kalaazar.
    KIRK R; MOHAMMED HAMAD SATI
    Ann Trop Med Parasitol; 1947 May; 41(1):14-21. PubMed ID: 20249285
    [No Abstract]   [Full Text] [Related]  

  • 17. [About stibio-intolerance and stibio-resistance in the treatment of internal leishmaniasis].
    MURANO G
    Prog Med (Napoli); 1945 Jan; 1():156-60. PubMed ID: 21013812
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cutaneous leishmaniasis with methylglucamine antimoniate (2.168 R. P.)].
    RAGU J; SCHNEIDER J
    Ann Dermatol Syphiligr (Paris); 1947 Feb; 7(2):38. PubMed ID: 20253292
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of kalaazar with sodium antimony gluconate (stibatin) further observations on the treatment of 32 cases.
    CHAKRAVARTY KC
    Ind Med Gaz; 1945 Oct; 80(10):507-11. PubMed ID: 21017335
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stibiosusceptibility and stibioresistance; various ways of responding of the leishmaniosis to antimonial treatment].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Rev Esp Pediatr; 1948; 4(6):810-30. PubMed ID: 18111436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.